Kate E Lines
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
- Neurology top 10%
- Neuroblastoma Research and Treatments
Papers in
- Epidemiology 26
- Neuroendocrine Tumor Research Advances 26
- Oncology 17
- Lung Cancer Research Studies 12
- Pancreatic and Hepatic Oncology Research 8
- Co-authors
- Rajesh V. Thakker (39 shared papers)Mark Stevenson (23 shared papers)Maria Luisa Brandi (3 shared papers)Nancy D. Perrier (3 shared papers)Sunita Agarwal (1 shared paper)Gerlof D. Valk (4 shared papers)Morten Frost (1 shared paper)Tatjana Crnogorac‐Jurcevic (3 shared papers)
- Journals
- Endocrine Related Cancer (4 papers)Oncogene (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Endocrine Connections (2 papers)The Lancet Diabetes & Endocrinology (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Kate E Lines
42 papers receiving 644 citations
Peers
Comparison fields: 5 of 61
- Nephrology 95
- Neurology 160
- Epidemiology 306
- Oncology 223
- Endocrinology, Diabetes and Metabolism 106
Countries citing papers authored by Kate E Lines
This map shows the geographic impact of Kate E Lines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate E Lines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate E Lines more than expected).
Fields of papers citing papers by Kate E Lines
This network shows the impact of papers produced by Kate E Lines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate E Lines. The network helps show where Kate E Lines may publish in the future.
Co-authors
The 25 scholars most cited alongside Kate E Lines, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 123 | |
| 2 | 2018 | 51 | |
| 3 | 2012 | 46 | |
| 4 | 2017 | 40 | |
| 5 | 2015 | 33 | |
| 6 | 2012 | 32 | |
| 7 | 2018 | 30 | |
| 8 | 2017 | 28 | |
| 9 | 2020 | 24 | |
| 10 | 2016 | 24 | |
| 11 | 2023 | 21 | |
| 12 | 2015 | 17 | |
| 13 | 2018 | 17 | |
| 14 | 2017 | 16 | |
| 15 | 2018 | 14 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 11 | |
| 18 | 2019 | 11 | |
| 19 | 2020 | 9 | |
| 20 | 2023 | 8 |
About Kate E Lines
Kate E Lines is a scholar working on Epidemiology, Oncology, Molecular Biology, Neurology and Endocrinology, Diabetes and Metabolism, having authored 47 papers that have together received 649 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (26 papers), Neuroblastoma Research and Treatments (13 papers), Lung Cancer Research Studies (12 papers), Pancreatic and Hepatic Oncology Research (8 papers), Pituitary Gland Disorders and Treatments (8 papers), Chromatin Remodeling and Cancer (5 papers), Parathyroid Disorders and Treatments (5 papers) and S100 Proteins and Annexins (3 papers). The work is most often cited by research in Nephrology (95 citations), Neurology (160 citations), Epidemiology (306 citations), Oncology (223 citations) and Endocrinology, Diabetes and Metabolism (106 citations). Kate E Lines has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Rajesh V. Thakker, Mark Stevenson, Maria Luisa Brandi, Nancy D. Perrier, Sunita Agarwal, Gerlof D. Valk, Morten Frost, Tatjana Crnogorac‐Jurcevic, Claude Chelala and Ashley Grossman. Their work appears in journals such as Endocrine Related Cancer, Oncogene, The Journal of Clinical Endocrinology & Metabolism, Endocrine Connections and The Lancet Diabetes & Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.